Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Jun;193(5):988-993.
doi: 10.1111/bjh.17416. Epub 2021 Mar 22.

Deficient mitophagy pathways in sickle cell disease

Suella Martino  1   2   3 , Jean-Benoit Arlet  3   4 , Marie-Hélène Odièvre  1   2   3   5 , Vincent Jullien  4 , Martina Moras  1   2   3 , Claude Hattab  1   2   3 , Thibaud Lefebvre  3   6   7 , Laurent Gouya  3   6   7 , Mariano A Ostuni  1   2   3 , Sophie D Lefevre  1   2   3 , Caroline Le Van Kim  1   2   3
Affiliations
Clinical Trial

Deficient mitophagy pathways in sickle cell disease

Suella Martino et al. Br J Haematol. 2021 Jun.

Abstract

Sickle cell disease (SCD) is characterised by chronic haemolysis and oxidative stress. Herein, we investigated 30 SCD patients and found 40% with elevated mitochondria levels (SS-mito+ ) in their mature red blood cells, while 60% exhibit similar mitochondria levels compared to the AA group (SS-mito- ). The SS-mito+ patients are characterised by higher reticulocytosis and total bilirubin levels, lower foetal haemoglobin, and non-functional mitochondria. Interestingly, we demonstrated decreased levels of mitophagy inducers, PINK1 and NIX, and higher levels of HSP90 chaperone in their red cells. Our results highlighted for the first time an abnormal retention of mitochondria in SCD linked with mitophagy-related proteins.

Keywords: PINK1/NIX; mitochondria; mitophagy; sickle cell disease.

PubMed Disclaimer

References

    1. Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127(3):750-60.
    1. Ware RE. Technological advances in sickle cell disease. Blood Cells Mol Dis. 2017;67:102-3.
    1. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med. 2008;44(8):1506-28.
    1. Sivilotti ML. Oxidant stress and haemolysis of the human erythrocyte. Toxicol Rev. 2004;23(3):169-88.
    1. Malleret B, Xu F, Mohandas N, Suwanarusk R, Chu C, Leite JA, et al. Significant biochemical, biophysical and metabolic diversity in circulating human cord blood reticulocytes. PLoS One. 2013;8(10):e76062.

Publication types

LinkOut - more resources